Interferon-α therapy for chronic hepatitis C in special patient populations

Digestive Diseases and Sciences

Volumn 41, Issue 12 SUPPL., 1996, Pages

  Marcellin, Patrick ^a   Boyer, Nathalie ^a   Behamou, Jean Pierre ^a   Erlinger, Serge ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

allograft transplantation; hemodialysis; hepatitis C virus; human immunodeficiency virus; interferon ; mixed cryoglobulinemia

Indexed keywords

ALPHA INTERFERON;

CONFERENCE PAPER; CRYOGLOBULINEMIA; HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; VIRUS REPLICATION;

EID: 0030466612     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02087888     Document Type: Conference Paper

References (27)

1. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22:1050-1056, 1995
2. Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Reynes M, Urdea M, Bréchot C, Bismuth H: The course of hepatitis C infection after liver transplantation. Hepatology 20:1137-1143, 1994
3. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH: Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 97:1559-1561, 1989
4. Hay CRM, Preston FE, Triger DR, Underwood JCE: Progressive liver disease in haemophilia: An understated problem? Lancet 1:1495-1498, 1985
5. Eyster ME, Whitehurst DA, Catalano PM, McMillan CW, Goodnight SH, Kasper CK, Gill JC, Aledort LM, Hilgartner MW, Levine PH, Edson JR, Hathaway WE, Lusher JM, Gill FM, Poole WK, Shapiro SS: Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood 66:1317-1320, 1985
6. Makris M, Preston FE, Triger DR, Underwood JCE, Choo QL, Kuo G, Houghton M: Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335:1117-1119, 1990
7. Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI: A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 78:1672-1677, 1991
8. Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Bréchot C: Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 47:1412-1418, 1995
9. Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y: The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 53:763-765, 1992
10. Chan T-M, Lok ASF, Cheng IKP, Chan RT: A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 104:862-868, 1993
11. Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolen J: Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections. Transplantation 45:402-405, 1988
12. Thervet E, Pol S, Legendre Ch, Gagnadoux M-F, Cavalcanti R, Kreis H: Low-dose recombinant leukocyte interferon-α treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation 58:625-628, 1994
13. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durant D: Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59:1426-1431, 1995
14. Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C: Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108:1088-1096, 1995
15. Wright HI, Gavaler JS, Van Thiel DH: Preliminary experience with α-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 53:121-124, 1992
16. Van Thiel DH, Baddour N, Fagiuoli S, Wright HI, Gavaler JS: Alpha interferon treatment of hepatitis C in patients with liver allografts treated with either FK-506 or cyclosporin A. Eur J Gastroenterol Hepatol 6:787-791, 1994
17. Féray C, Samuel D, Gigou M, Paradis V, David MF, Lemonnier C, Reynès M, Bismuth H: An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 22:1084-1089, 1995
18. Gadano AC, Mosnier J-F, Durand F, Martinot-Peignoux M, Marcellin P, Degott C, Belghiti J, Erlinger S, Benhamou J-P, Bernuau JR: α-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen. Transplantation 59:1627-1629, 1995
19. Bizollon T, Ducerf C, Trépo C: New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin. J Hepatol 23(suppl 2):22-25, 1995
20. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 15:101-108, 1995
21. Marcellin P, Benhamou JP: Autoimmune disorders associated with hepatitis C. In Progress in Liver Diseases, XIII, Boyer JL, Ockner RK (eds). Philadelphia, WB Saunders Company, 1995, pp 247-267
22. Marcellin P, Descamps V, Martinot-Peignoux M, Larqu D, Xu L, Boyer N, Pham B-N, Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou J-P: Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272-277, 1993
23. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756, 1994
24. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
25. Boyer N, Marcellin P, Degott C, Degos F, Saimot AG, Erlinger S, Benhamou JP, and the Comité des anti-viraux: Recombinant interteron-a for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J Infect Dis 165:723-726, 1992
26. Marcellin P, Boyer N, Areias J, Erlinger S, Benhamou JP: Comparison of efficacy of alpha interferon in former intravenous drug addicts with chronic hepatitis C with or without HIV infection. Gastroenterology 106(4 Pt 2):A938, 1994 (abstract)
27. Cribier B, Rey D, Schmitt C, Lang J-M, Kim A, Stoll-Keller F: High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131-1136, 1995